Our observation may be in line with previous studies in breast cancer that observed high FOXP1 protein expression to be a favorable prognostic marker in patients with estrogen receptor (ER)-positive breast cancer (Bates et al. 2008; Fox et al. 2004; Rayoo et al. 2009). The gene discussed is ESR1; the disease is breast carcinoma.